Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
13.00
-0.61 (-4.48%)
At close: Apr 4, 2025, 4:00 PM
12.70
-0.30 (-2.30%)
After-hours: Apr 4, 2025, 8:00 PM EDT

Oscar Health Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Oscar Health stock have an average target of 20.21, with a low estimate of 12 and a high estimate of 28. The average target predicts an increase of 55.46% from the current stock price of 13.00.

Analyst Consensus: Hold
Target Low Average Median High
Price $12 $20.21 $21 $28
Change -7.69% +55.46% +61.54% +115.38%

Analyst Ratings

The average analyst rating for Oscar Health stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 000000
Buy 444442
Hold 322223
Sell 012222
Strong Sell 000000
Total 778887

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Wells Fargo
Wells Fargo
Hold
Downgrades
$20$16
Hold Downgrades $20$16 +23.08% Mar 13, 2025
Jefferies
Jefferies
Sell
Initiates
$12
Sell Initiates $12 -7.69% Dec 10, 2024
B of A Securities
B of A Securities
Sell
Downgrades
$21$14
Sell Downgrades $21$14 +3.85% Nov 6, 2024
UBS
UBS
Hold
Initiates
$23
Hold Initiates $23 +76.92% Oct 7, 2024
Piper Sandler
Piper Sandler
Buy
Reiterates
$28
Buy Reiterates $28 +115.38% Sep 10, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
11.40B
from 9.18B
Increased by 24.21%
Revenue Next Year
11.46B
from 11.40B
Increased by 0.55%
EPS This Year
0.76
from 0.10
Increased by 657.72%
EPS Next Year
1.02
from 0.76
Increased by 35.12%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
390.99M1.89B3.96B5.86B9.18B11.40B11.46B13.76B
Revenue Growth
-17.79%384.43%109.27%47.92%56.54%24.21%0.55%20.07%
EPS
-14.16-3.20-2.85-1.220.100.761.021.82
EPS Growth
-----657.72%35.12%77.67%
Forward PE
-----17.1612.707.15
No. Analysts -----10108
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 11.9B 13.3B 15.1B
Avg 11.4B 11.5B 13.8B
Low 10.4B 9.8B 11.0B

Revenue Growth

Revenue Growth 202520262027
High
29.2%
16.4%
32.0%
Avg
24.2%
0.6%
20.1%
Low
13.1%
-14.0%
-3.9%

EPS Forecast

EPS 202520262027
High 0.92 1.94 2.49
Avg 0.76 1.02 1.82
Low 0.59 0.39 1.17

EPS Growth

EPS Growth 202520262027
High
824.0%
156.4%
143.1%
Avg
657.7%
35.1%
77.7%
Low
488.0%
-48.3%
13.9%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.